Items where authors include "Cornec-Le Gall, E."
Article
Devuyst, O. orcid.org/0000-0003-3744-4767, Ahn, C., Barten, T.R.M. et al. (24 more authors) (2025) KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD). Kidney International, 107 (2). S1-S239. ISSN 0085-2538
Torres, V.E., Ahn, C., Barten, T.R.M. et al. (27 more authors) (2025) KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD): executive summary. Kidney International, 107 (2). pp. 234-254. ISSN 0085-2538
Zagorec, N., Calamel, A., Delaporte, M. et al. (24 more authors) (2024) Clinical spectrum and prognosis of atypical autosomal dominant polycystic kidney disease caused by monoallelic pathogenic variants of IFT140. American Journal of Kidney Diseases. ISSN 0272-6386
Taylor, J., Thomas, R., Metherall, P. et al. (15 more authors) (2024) An artificial intelligence generated automated algorithm to measure total kidney volume in ADPKD. Kidney International Reports, 9 (2). pp. 249-256. ISSN 2468-0249
Müller, R.-U., Lianne Messchendorp, A., Birn, H. et al. (20 more authors) (2022) An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Kidneys, 11 (1). pp. 37-39. ISSN 2307-1257
Müller, R.-U., Messchendorp, A.L., Birn, H. et al. (20 more authors) (2022) An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: consensus statement on behalf of the ERA Working Group on Inherited Kidney Disorders, the European Rare Kidney Disease Reference Network and Polycystic Kidney Disease International. Nephrology Dialysis Transplantation, 37 (5). pp. 825-839. ISSN 0931-0509
Senum, S.R., Li, Y.S.M., Benson, K.A. et al. (25 more authors) (2022) Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. The American Journal of Human Genetics, 109 (1). pp. 136-156. ISSN 0002-9297
Huynh, V.T., Audrézet, M.-P., Sayer, J.A. et al. (17 more authors) (2020) Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease. Kidney International, 98 (2). pp. 476-487. ISSN 0085-2538
Hopp, K. orcid.org/0000-0002-2420-2358, Cornec-Le Gall, E., Senum, S.R. orcid.org/0000-0002-5489-9117 et al. (17 more authors) (2020) Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease. Kidney International, 97 (2). pp. 370-382. ISSN 0085-2538
Proceedings Paper
Winterbottom, J., Simms, R., Caroli, A. et al. (10 more authors) (2021) MO023: Flank pain has a major negative impact on health-related quality of life in ADPKD: The CYSTic I Study. In: Nephrology Dialysis Transplantation. 58th ERA-EDTA Congress, 05-08 Jun 2021, Berlin, Germany. Oxford University Press , i102.